Systemic injection of CK2.3, a novel peptide acting downstream of bone morphogenetic protein receptor BMPRIa, leads to increased trabecular bone mass.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Beth Bragdon |
| Publication date | October 20, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |